Bailard’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10M Sell
143,373
-6,387
-4% -$446K 0.23% 96
2025
Q1
$11M Buy
149,760
+712
+0.5% +$52.3K 0.28% 80
2024
Q4
$9.77M Buy
149,048
+760
+0.5% +$49.8K 0.25% 92
2024
Q3
$11.6M Buy
148,288
+21,189
+17% +$1.65M 0.3% 81
2024
Q2
$9.91M Buy
127,099
+1,286
+1% +$100K 0.27% 86
2024
Q1
$8.52M Sell
125,813
-1,258
-1% -$85.2K 0.24% 95
2023
Q4
$8.56M Sell
127,071
-1,914
-1% -$129K 0.25% 87
2023
Q3
$8.73M Buy
128,985
+3,553
+3% +$241K 0.29% 78
2023
Q2
$8.98M Sell
125,432
-14,238
-10% -$1.02M 0.31% 74
2023
Q1
$9.69M Buy
139,670
+102
+0.1% +$7.08K 0.35% 68
2022
Q4
$9.46M Buy
139,568
+7,756
+6% +$526K 0.36% 67
2022
Q3
$7.23M Buy
131,812
+9,122
+7% +$500K 0.3% 79
2022
Q2
$8.11M Sell
122,690
-6,410
-5% -$424K 0.32% 70
2022
Q1
$8.57M Sell
129,100
-821
-0.6% -$54.5K 0.29% 81
2021
Q4
$7.57M Sell
129,921
-8,036
-6% -$468K 0.24% 94
2021
Q3
$8.29M Buy
137,957
+1,424
+1% +$85.5K 0.28% 84
2021
Q2
$8.18M Sell
136,533
-8,798
-6% -$527K 0.28% 86
2021
Q1
$7.23M Buy
145,331
+111,211
+326% +$5.53M 0.27% 84
2020
Q4
$1.71M Sell
34,120
-8,370
-20% -$419K 0.08% 167
2020
Q3
$2.33M Buy
42,490
+1,066
+3% +$58.4K 0.12% 140
2020
Q2
$2.19M Sell
41,424
-13,574
-25% -$718K 0.12% 136
2020
Q1
$2.46M Buy
54,998
+3,838
+8% +$171K 0.17% 109
2019
Q4
$2.55M Sell
51,160
-5,100
-9% -$254K 0.14% 129
2019
Q3
$2.51M Buy
56,260
+15,000
+36% +$669K 0.15% 135
2019
Q2
$1.7M Buy
41,260
+4,000
+11% +$165K 0.1% 172
2019
Q1
$1.51M Buy
+37,260
New +$1.51M 0.09% 188
2013
Q4
Sell
-8,602
Closed -$223K 226
2013
Q3
$223K Sell
8,602
-63,402
-88% -$1.64M 0.04% 193
2013
Q2
$1.7M Buy
+72,004
New +$1.7M 0.31% 69